Impact BioMedical Inc.

NYSEAM:IBO Stock Report

Market Cap: US$24.8m

Impact BioMedical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NYSEAM:IBO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Sep 24BuyUS$2,330Sentinel Brokers Company, Inc, Asset Management ArmCompany1,000US$2.33
17 Sep 24BuyUS$153,220Sentinel Brokers Company, Inc, Asset Management ArmCompany57,800US$2.69

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of IBO?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders95,7780.711%
Public Companies6,246,84746.4%
Institutions7,123,43452.9%

Dilution of Shares: IBO only recently listed within the past 12 months


Top Shareholders

Top 8 shareholders own 117.12% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
61.4%
The Vanguard Group, Inc.
7,064,274US$15.3m0.01%no data
39.7%
Alset Inc.
4,568,165US$9.9m0%no data
14.6%
DSS, Inc.
1,678,682US$3.6m42.4%no data
0.83%
Frank Heuszel
95,475US$206.2k0%no data
0.51%
Sentinel Brokers Company, Inc, Asset Management Arm
58,800US$127.0k0%no data
0.0031%
BlackRock, Inc.
360US$777.30%no data
0.0016%
Jason Grady
182US$392.40%no data
0.001%
Todd Macko
121US$260.80%no data